Webinars and Sponsored Roundtables — Register Now
Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
Thermo Fisher Scientific
| Company | Thermo Fisher Scientific |
|---|---|
| Name of system | Ion Torrent Genexus Integrated Sequencer; Ion Torrent Genexus Dx Integrated Sequencer |
| City, State | Carlsbad, CA |
| Phone | 800-955-6288 |
| Website | |
| System application/FDA cleared or approved | Genexus: research use; Genexus Dx: in vitro diagnostic use/Genexus: —; Genexus Dx: not required |
| Country where designed/Manufactured | U.S./Singapore |
| First year sold in U.S./First year installed in U.S. | 2019/2019 |
| System sold internationally | Genexus: yes (worldwide); Genexus Dx: yes (multiple countries) |
| Dimensions of sequencer (H × W × D)/Footprint of sequencer | open: 81.1 × 58.5 × 43.5 in.; closed: 66.1 × 41.9 × 32.1 in./ |
| Accessory equipment supplied with sequencer at no cost | open: 17.67 sq. ft.; closed: 9.36 sq. ft. |
| Type of computer supplied with sequencer | — |
| Analysis options provided with sequencer | computer for analysis and operations combined |
| Where library preparation is performed | onboard, cloud based, local server |
| Bioinformatics tools provided with sequencer | computer for analysis and operations combined |
| Sequencer supplied with UPS (uninterruptible power supply) | Ion Torrent Genexus Software (optional: Oncomine Reporter) |
| Electrical connection required for sequencer | no |
| List price of entire sequencer and necessary components | 100–240 VAC |
| Purchase options | — |
| Warranties offered | purchase, trade in, lease, finance |
| Training included/Total time for basic training per operator | first year included with purchase; extended warranty avail. |
| Training location/Follow-up training available | yes/2 days |
| Maximum No. of samples amplified in a single amplification event | at customer or vendor site/yes (extra charge) |
| Read length/Percent bases >Q30 | up to 400 bp/— |
| Paired-end capability/Tag lengths/Spans | up to 400 bp/— |
| Fragment/Tag lengths/Spans | — |
| Mate pair/Tag lengths/Spans | — |
| Single end/Tag lengths/Spans | — |
| RNA sequencing/Tag lengths/Spans | yes/—/up to 400 bp |
| ChIP sequencing/Tag lengths/Spans | — |
| Bisulfite sequencing/Tag lengths/Spans | — |
| Maximum No. of reads or fragments sequenced per single-end run | — |
| Maximum No. of reads or fragments sequenced per paired-end run | 48–60 million at 200–400 bp (GX5); 80–100 million at 200 bp (GX7) |
| Total No. of nucleotides (bases) sequenced per run | — |
| Wet lab bench time for sequencing preparation | 9.6–12 Gb at 200 bp (GX5); 16–20 Gb at 200 bp (GX7) |
| Sequencing run time | 10 minutes |
| Total time for generating standard gDNA library | 19–24 hours (includes automated library prep) |
| • Paired end | — |
| • Fragment | — |
| Hands-on time for the following: | — |
| • Paired end | |
| • Fragment | |
| • Mate pair | — |
| • Single end | — |
| • RNA sequencing | — |
| • ChIP sequencing | — |
| • Bisulfite sequencing | — |
| Library preparation integrated in system as standard offering | yes (AmpliSeq, AmpliSeq HD) |
| Library preparation offered separately for additional charge | no |
| Cost of sequencing reagents per run | — |
| Reagent tracking method | RFID, barcode reader |
| • Type of reagent information tracked | expiration date, lot and part Nos., placement |
| Shipping conditions for amplification/sequencing reagents | -20°C, 4°C, ambient (variable based on product)/-20°C, 4°C, ambient (variable based on product) |
| Storage conditions for amplification/sequencing reagents | -20°C, 4°C, ambient (variable based on product)/-20°C, 4°C, ambient (variable based on product) |
| Shelf life of amplification/sequencing reagents | 12–36 months from manufacture date (variable based on product)/ 12–36 months from manufacture date (variable based on product) |
| System requires a control sample on sequencing run | optional |
| • Company offers a sequencing control | yes (additional charge) |
| Sequencing system control software and devices to start run/for data analysis | Ion Torrent Genexus Software/Genexus Software, Oncomine Reporter |
| Complete walkaway automation for amplification, sequencing, and variant calling | yes |
| Remote system monitoring | yes |
| Total time required for setup of amplification, sequencing, and variant calling steps | 10 minutes |
| Maximum No. of libraries sequenced in a single run | 48 samples or 96 libraries |
| System includes secondary data-analysis software developed by company | yes (Ion Reporter, Oncomine Reporter) |
| System includes post-sequencing data-analysis software | yes |
| Mutations detectable via data-analysis software | substitutions, indels, copy number changes, fusions |
| System can generate a variant report | yes |
| Types of maintenance plans available/mean time between failures | AB Assurance, AB Platinum NGS/— |
| No. of field application scientists and engineers based in U.S. | 450 |
| • Weekly | none |
| • Monthly | none |
| • Pre-run | none |